EDITOR'S LETTER

EYE ON CHINA

• Genetic mechanism behind aging rate uncovered
• China launches survey of endangered porpoises in Yangtze River
• Academic institutes and companies join forces to boost precision nutrition research
• Gigantic DNA database to be built in Nanjing
• Home test kit for cervical screening developed by BGI
• Chinese HPV vaccine gets permission for clinical testing
• Ineffective baby vaccines by two companies recalled
• Robot scores high result on national doctor qualification test
• Head transplant 'never' to be allowed
• China ranks second in Global Science Innovation
• Veolia to support Danone Nutricia Wuxi plant in China
• Chinese drug delivery devices market to reach USD638.4 million by 2023

FEATURES

• New hope for butterfly children
• Living with food allergy

SPOTLIGHTS

• An ophthalmic hospital with wings

COLUMNS

• Digital health technology to combat world’s number one killer
• Cancer Immunotherapy: where we stand and move forward

INSIDE INDUSTRY

• Asia-Pacific, the rising region for cancer vaccine clinical trials
• Non-small cell lung cancer has largest number of clinical trials in Australia
• Global dermatology pipeline to see shift towards increased usage of biologics
• FDA approves first 0.1 mg auto-injector for life-threatening allergic reactions in infants and small children
• FDA approves first two-drug regimen for certain patients with HIV
• New early-breast cancer drug to be made available in Australia, New Zealand and South-East Asia
• Multi-omic data analytics collaboration between the University of Oxford and Holmusk
• NRGene’s genomic analysis project with Monsanto advances
• Samsung BioLogics receives first FDA approval at world's largest plant
• TLC welcomes Mayor of Leiden and delegation to Taipei headquarter
• Warren Wang appointed senior vice president and president of Asia Pacific of Boston Scientific
• MiRXES reveals globalisation plans for 2018 and 2019
• QuintilesIMS is now IQVIA
• Quotient Sciences launches as the new global identity for Quotient Clinical
• ESMO Asia 2017 Congress
• More care is needed for cancer supportive care
• ALEX study shows alectinib 600 mg more effective than crizotinib in Asian lung cancer patients
• Study analyses mutations in cerebrospinal fluid in lung cancer with brain metastases
• Study finds all Myanmar mouth cancer patients chew betel quid

BIOBOARD

ASIA

• Gene mutation discovered to cause severe growth retardation in newly discovered disease
• Singapore scientists make major breakthrough to treat fibrotic diseases that cause organ impairment and failure
• DcR3 is the key factor of endometriosis
• Singapore Volition signs MOU with National Taiwan University to conduct two large clinical studies

EUROPE & CIS

• NPL relaunches to accelerate access to new health innovations
• The hard truth about Eczema: It's something in the water
• Gastric acid suppressant lansoprazole may target tuberculosis
• Long-term aspirin use reduces incidence of digestive cancers by up to 47 per cent

AMERICAS

• Rockefeller University biologist Michael W. Young honored with Nobel Prize for pioneering studies on circadian rhythm
• Ohio physicians contribute to groundbreaking stroke research
• A poorly explored immune cell may impact cancer immunity and immunotherapy
• Superbugs have a new foe
• Approved drug or herbal treatment: How to choose?

CONFERENCE CALENDAR